Celltrion has won new “domestic” approval for a Humira (adalimumab) biosimilar with the same dosage and formulation as the currently marketed product, drawing the industry’s attention to the reason.According to the Ministry of Food and Drug Safety, Celltrion obtained domestic approval for Yuflyma Pe
Celltrion said on Friday that it won the first trial of two patents (Patent No. US 9254338, US 9669069) against Regeneron, a leading biotechnology company in the United States.The lawsuit regards a U.S. patent on the treatment of angiogenic ophthalmic diseases of Eylea (ingredient: aflibercept), an
Researchers at Severance Hospital have identified the risk of developing diabetes using immunotherapy.Immunotherapies are drugs that prevent cancer cells from evading the body's immune system, allowing immune cells to better recognize and attack cancer cells.After the first immunotherapy agent recei
“Korean biotechnology companies’ scientific quality does not lag behind other countries. However, they fall somewhat short of understanding what the medical community and biotech industry want.”So said Philip Tagari, vice chair for Amgen’s R&D, who visited Korea to attend the “Second KHIDI-AMGEN Sci
A government survey showed that patients who tried telemedicine during the Covid-19 pandemic are highly satisfied, with almost nine out of 10 users responding that they would continue using non-contract treatment.The Korea Health Industry Development Institute (KHIDI) released the results of its sur
To help foster healthcare startups, BMS Korea held the “Seoul BMS Innovation Square Challenge” award ceremony with the Seoul Municipal Government and the Korea Health Industry Development Institute (KHIDI) at Seoul Bio Hub last week.The challenge is an open innovation partnering program pushed joint
Korea's new Covid-19 cases rose to the highest Thursday figure in two months as officials brace for winter resurgence.According to the Korea Disease Control and Prevention Agency (KDCA), Korea added 55,437 new Covid-19 infections, including 39 cases from abroad, bringing the total caseload to 26,412
Ten Korean oncologists put their names on the list of the world’s most influential researchers, heightening the status of the country’s medicine.On Wednesday, Clarivate Plc, a global academic information analysis company, announced the list of Highly Cited Researchers (HCR), a who’s who of researche
Dong-A ST said it has completed the global phase 3 clinical trial of DMB-3115, a biosimilar referencing Janssen’s plaque psoriasis treatment Stelara (ingredient: ustekinumab).The company initially initiated the global phase 3 clinical trial of DMB-3115 in the U.S. in 2021 and expanded it to eight ot
SK Bioscience, one of Korea’s leading vaccine makers, said it donated 3 billion won ($2.2 million) to the International Vaccines Institute (IVI) on Wednesday to advance global vaccine research and development.The donation will be used to support vaccine R&D, equipment, and device purchases, it added
Philips Korea said Thursday that it has appointed Park Jae-in, former general manager (GM) at Abbott Korea, as its new CEO.New CEO Park will also serve as head of Philips Korea’s health systems business division, which provides professional healthcare solutions, the company said.Park has more than 2
CHA Vaccine Institute announced it is developing a mixed vaccine to prevent Covid-19 and influenza at the 2022 Hwasun International Vaccine Forum last Friday.The research institute said the combination vaccine aims to improve convenience and preventive effects for the elderly. The candidate substanc
The Ministry of Education said 2,317 out of 508,030 students who applied for the college scholastic ability test (CSAT), scheduled for Thursday, had tested positive for Covid-19 and were undergoing mandatory quarantine as of midnight Tuesday.The figure is a drastic increase from 2021 when only 96 te
Shares of GC MS were bullish on Wednesday after health officials confirmed the third monkeypox case in Korea.At the market close on Wednesday, the company's shares ended at 6,000 won ($4.53), up 3.45 percent from the previous trading day.Investors mistakenly considered GC MS as a monkeypox-related s
A survey showed that Korean medical institutions recognize the need for and importance of introducing ESG management. Still, fewer than half of them have personnel and departments exclusively responsible for it.The Korean Health Industry Development Institute (KHIDI) released the results of its surv
LegoChem Bioscience said it signed an antibody-drug conjugate (ADC) joint research and development agreement with NextCure, a U.S. pharmaceutical company.Under the accord, the two companies plan to discover new ADC anticancer drugs by utilizing Next Cure's B7-H4 antibody and LegoChem's ADC platform
Lunit, a company specializing in medical artificial intelligence (AI) solutions, said on Wednesday that it acquired the operating rights in a bid for the Breast Screening New South Wales (BSNSW) state program in Australia.BSNSW is an Australian state-run program that provides free breast cancer scre
Roche Korea’s Tecentriq (atezolizumab) has expanded its indication to postoperative adjuvant therapy for the first time among lung cancer immunotherapies but fell short of expectations, industry watchers said on Wednesday.Last Friday, the Ministry of Food and Drug Safety approved the use of Tecentri
Humasis, an in vitro diagnosis kit maker, saw its sales drop sharply in the third quarter.According to industry watchers on Wednesday, the conflict between the company and its minority shareholders has also expanded to a management dispute, deepening worries about corporate competitiveness.Humasis u
President Yoon Suk-yeol pledged Korea's active contribution to strengthening international health solidarity during a session focusing on health at the G20 Indonesia Summit."The preciousness of freedom and the importance of solidarity were reminded once again at a time when the global community is r